1. Home
  2. ITRM vs APYX Comparison

ITRM vs APYX Comparison

Compare ITRM & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • APYX
  • Stock Information
  • Founded
  • ITRM 2015
  • APYX 1982
  • Country
  • ITRM Ireland
  • APYX United States
  • Employees
  • ITRM N/A
  • APYX N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • ITRM Health Care
  • APYX Health Care
  • Exchange
  • ITRM Nasdaq
  • APYX Nasdaq
  • Market Cap
  • ITRM 37.7M
  • APYX 36.2M
  • IPO Year
  • ITRM 2018
  • APYX 1987
  • Fundamental
  • Price
  • ITRM $1.30
  • APYX $0.93
  • Analyst Decision
  • ITRM Strong Buy
  • APYX Hold
  • Analyst Count
  • ITRM 1
  • APYX 2
  • Target Price
  • ITRM $5.00
  • APYX N/A
  • AVG Volume (30 Days)
  • ITRM 364.7K
  • APYX 68.5K
  • Earning Date
  • ITRM 05-12-2025
  • APYX 05-08-2025
  • Dividend Yield
  • ITRM N/A
  • APYX N/A
  • EPS Growth
  • ITRM N/A
  • APYX N/A
  • EPS
  • ITRM N/A
  • APYX N/A
  • Revenue
  • ITRM N/A
  • APYX $48,102,000.00
  • Revenue This Year
  • ITRM N/A
  • APYX $1.85
  • Revenue Next Year
  • ITRM $150.10
  • APYX $7.72
  • P/E Ratio
  • ITRM N/A
  • APYX N/A
  • Revenue Growth
  • ITRM N/A
  • APYX N/A
  • 52 Week Low
  • ITRM $0.81
  • APYX $0.76
  • 52 Week High
  • ITRM $3.02
  • APYX $1.99
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 56.35
  • APYX 45.16
  • Support Level
  • ITRM $1.01
  • APYX $0.89
  • Resistance Level
  • ITRM $1.42
  • APYX $1.02
  • Average True Range (ATR)
  • ITRM 0.09
  • APYX 0.15
  • MACD
  • ITRM 0.03
  • APYX 0.00
  • Stochastic Oscillator
  • ITRM 73.17
  • APYX 59.49

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: